Events and Presentations

Corporate Presentation – February 2026 1.8 MB

Anaphylm™ (dibutepinephrine) Sublingual Film Complete Response Letter Supplemental Material 1.1 MB

Anaphylm Pre-NDA Meeting Supplemental Material 525.4 KB

Anaphylm™ (epinephrine) Sublingual Film Oral Allergy Syndrome Challenge Study Supplemental Materials 1.5 MB

Anaphylm™ (epinephrine) Sublingual Film Pivotal Study and Type C Meeting Supplemental Materials 1.5 MB

Anaphylm™(epinephrine) Sublingual Film Pilot Clinical Studies Supplemental Materials 778.4 KB

AQST-109: EPIPHAST II Results 2 MB

AQST-109: Topline Results from Phase 1 PK Study 594.4 KB